Chlamydia pneumonia is the causative agent of respiratory tract infectious diseases and spread worldwidely through aerosols. Chlamydia pneumonia may cause pneumonia, bronchitis, pharyngitis, sinusitis, stimulate primary pharyngitis. 10-20% of adults and children may get community acquired pneumonia according to chlamydia pneumonia, while 10-20% adults may get acute bronchitis. In fact, most of the chlamydia pneumonia infection is in the type of subclinical, with no symptoms and rarely cause significant disease, and will be much more serious without treatment.
The positive results of infected people showed that the concentration of chlamydia pneumonia goes with age, which is lower in children but peaking in middle-aged people. It is indicated that chronic infection of chlamydia pneumonia is one of the factors that cause the atherosclerosis. The diagnosis of chlamydia pneumonia infection by
serological methods is still one of the bases for clinical diagnosis so far.
Detection of chlamydia pneumonia antibody is widely used in clinical diagnosis for its simple operation, quickness and low cost. In normal infection, Cpn-IgM can be detected as early as 3 weeks and disappear in about 2-6 months after infected, while Cpn-IgG can be detected in about 6-8 weeks. The detection of IgM is the basis for early diagnosis.
Hangzhou Yicare Biotech Co., Ltd.
We have 3 industrial parks with a total area of over 40,000 square meters. We sell more than 200 types of various IVD (in vitro diagnostic) reagents and related instruments. Most of our R&D team members have over 8 years of experience in the development of POCT products.
Hot Tags: chlamydia pneumonia antibody igm rapid test for early qualitative detection in serum, plasma, or whole blood for clinical diagnosis, China chlamydia pneumonia antibody igm rapid test for early qualitative detection in serum, plasma, or whole blood for clinical diagnosis manufacturers, suppliers
